EXL Announces Share Repurchase of 1,551,970 Shares

Rhea-AI Summary

EXL (NASDAQ: EXLS) announced a private share repurchase on December 15, 2025, buying 1,551,970 shares from Orogen Echo LLC for an aggregate purchase price of $63,373,143.

The purchase price per share was $40.834, equal to the volume-weighted average price over the five days prior to settlement. The repurchase was executed under a Stock Purchase Agreement dated December 15, 2025, and is separate from EXL’s existing $500 million share repurchase program. Orogen’s CEO Vikram Pandit will remain on EXL’s board as Lead Independent Director.

Positive

• Repurchased 1,551,970 shares on December 15, 2025
• Transaction value of $63,373,143 at $40.834 per share

Negative

• Repurchase executed outside the company’s $500 million repurchase program
• Company committed ~$63.4M of capital to the private purchase

Key Figures

Shares repurchased 1,551,970 shares Privately repurchased from Orogen on Dec 15, 2025

Aggregate purchase price $63,373,143 Total consideration for block repurchase from Orogen

Price per share $40.834 Repurchase price based on 5-day volume weighted average price

VWAP period 5 days Lookback window for calculating volume weighted average price

Repurchase program size $500 million Existing share repurchase program, separate from today’s block deal

Market Reality Check

$41.52 Last Close

Volume Volume 971,408 is slightly below 20-day average of 1,085,197, suggesting no outsized trading ahead of this buyback news. normal

Technical Shares at $41.64 are trading below the 200-day MA of $43.69 and about 20% under the 52-week high of $52.43.

Peers on Argus

Peers show mixed moves today: GENPACT (+0.65%), GDS (+0.22%), Kyndryl (-0.81%), EPAM (-0.60%), Parsons (-4.35%). EXLS’s modest gain of 0.29% appears company-specific rather than part of a sector-wide swing.

Historical Context

Date	Event	Sentiment	Move	Catalyst
Dec 11	Cloud migration update	Positive	+1.8%	Completed LifePRO Digital Suite migration to AWS using AI/ML services.
Nov 25	AI innovation event	Positive	+2.3%	Announced second annual IdeaTank AI innovation event at Nasdaq MarketSite.
Nov 20	Industry leadership award	Positive	-0.5%	Named Leader in Everest Group Clinical and Care Management Operations assessment.
Nov 06	Industry leadership award	Positive	-1.8%	Recognized as Leader in Everest Group P&C Insurance BPS PEAK Matrix assessment.
Nov 04	AI services ranking	Positive	+1.0%	Named Leader in ISG Provider Lens Generative AI Services report.

Pattern Detected

Recent positive news has produced mixed reactions, with 3 aligned and 2 divergent price moves, suggesting investors do not consistently reward announcements.

Recent Company History

Over the past few months, EXLS has highlighted multiple AI- and cloud-focused milestones. On Nov 4, 2025, it was named a Leader in ISG’s Generative AI Services report, followed by additional leadership recognitions in P&C insurance BPS and clinical and care management assessments in early November. A December 11 update detailed migration of LifePRO Digital Suite to AWS. A separate AI innovation event (“IdeaTank”) was announced on Nov 25. Today’s buyback fits a broader pattern of growth plus capital-return actions.

Market Pulse Summary

This announcement details a sizable block repurchase of 1,551,970 shares from a major holder, funded at a price of $40.834 per share based on a 5-day VWAP. It is separate from EXLS’s existing $500 million program, underscoring an ongoing capital-return focus. Investors can track future disclosures for additional repurchases, balance sheet impacts, and how these actions interact with the company’s AI-driven growth strategy and earnings trajectory.

Key Terms

volume weighted average price financial

"which is the volume weighted average price over the 5 days prior to settlement"

The volume weighted average price (VWAP) is a way to measure the average price of a security, such as a stock, over a specific period, taking into account how many units were traded at each price. It’s similar to calculating the average cost of items bought when some are more frequently purchased than others. Investors use VWAP to assess whether a security is being bought or sold at a fair price during trading.

share repurchase program financial

"which is separate from the Company’s $500 million share repurchase program"

A share repurchase program is when a company buys back its own shares from the marketplace. This reduces the total number of shares available, which can increase the value of each remaining share and signal confidence in the company's prospects. For investors, it often suggests that the company believes its stock is undervalued or that it has extra cash to return to shareholders.

common stock financial

"shares of the Company’s common stock from Orogen Echo LLC"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

AI-generated analysis. Not financial advice.

NEW YORK, Dec. 15, 2025 (GLOBE NEWSWIRE) -- EXL [NASDAQ: EXLS], a global data and AI company, announced that on December 15, 2025 it repurchased 1,551,970 shares of the Company’s common stock from Orogen Echo LLC (“Orogen”), an affiliate of The Orogen Group LLC, for an aggregate purchase price of $63,373,143, based on a purchase price per share of $40.834, which is the volume weighted average price over the 5 days prior to settlement. The shares were privately repurchased from Orogen under a Stock Purchase Agreement dated as of December 15, 2025, which is separate from the Company’s $500 million share repurchase program.

“This repurchase reflects our confidence in the performance of EXL and its future growth. We believe this is a unique opportunity to return capital to our stockholders and offers a compelling return on investment.   Orogen’s CEO Vikram Pandit will remain on EXL’s board as our Lead Independent Director, and we look forward to his continuing leadership and guidance,” said Rohit Kapoor, Chairman and CEO of EXL.

"We entered our partnership with EXL in 2018 with the firm belief that the company delivers best in class data and technology-driven operating solutions to its clients, and the company's growth trajectory over the last seven years has validated that belief. Orogen is pleased to help facilitate this stock repurchase and we look forward to the company's continued growth momentum,” said Vikram S. Pandit, Chairman and CEO of The Orogen Group.

To learn more about how EXL is making AI real for business, click here.

About EXL

EXL (NASDAQ: EXLS) is a global data and AI company that offers services and solutions to reinvent client business models, drive better outcomes and unlock growth with speed. EXL harnesses the power of data, AI, and deep industry knowledge to transform businesses, including the world's leading corporations in industries including insurance, healthcare, banking and capital markets, retail, communications and media, and energy and infrastructure, among others. EXL was founded in 1999 with the core values of innovation, collaboration, excellence, integrity and respect. We are headquartered in New York and have approximately 63,000 employees spanning six continents. For more information, visit www.exlservice.com.

About Orogen
The Orogen Group was created by Vikram S. Pandit and Atairos as a private operating company focused on making significant long-term control and other strategic investments in financial services companies and related businesses. Orogen delivers extensive resources and strategic and operational expertise to help its partner companies achieve their growth potential. The Orogen Group is based in New York. Additional information can be found at www.orogengroup.com.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. You should not place undue reliance on those statements because they are subject to numerous uncertainties and factors relating to EXL's operations and business environment, all of which are difficult to predict and many of which are beyond EXL’s control. Forward-looking statements include information concerning EXL’s possible or assumed future results of operations, including descriptions of its business strategy. These statements may include words such as “may,” “will,” “should,” “believe,” “expect,” “anticipate,” “intend,” “plan,” “estimate” or similar expressions. These statements are based on assumptions that we have made in light of management's experience in the industry as well as its perceptions of historical trends, current conditions, expected future developments and other factors it believes are appropriate under the circumstances. You should understand that these statements are not guarantees of performance or results. They involve known and unknown risks, uncertainties and assumptions. Although EXL believes that these forward-looking statements are based on reasonable assumptions, you should be aware that many factors could affect EXL’s actual financial results or results of operations and could cause actual results to differ materially from those in the forward-looking statements. These factors, which include our ability to maintain and grow client demand, our ability to hire and retain sufficiently trained employees, and our ability to accurately estimate and/or manage costs, rising interest rates, rising inflation and recessionary economic trends, are discussed in more detail in EXL’s filings with the Securities and Exchange Commission, including EXL’s Annual Report on Form 10-K. You should keep in mind that any forward-looking statement made herein, or elsewhere, speaks only as of the date on which it is made. New risks and uncertainties come up from time to time, and it is impossible to predict these events or how they may affect EXL. EXL has no obligation to update any forward-looking statements after the date hereof, except as required by federal securities laws.

Contact
Media
Keith Little
media.relations@exlservice.com

FAQ

What did EXL (EXLS) announce on December 15, 2025?

EXL repurchased 1,551,970 shares from Orogen Echo LLC for $63,373,143 at $40.834 per share.

How much did EXL pay per share in the December 15, 2025 repurchase (EXLS)?

EXL paid a volume-weighted average price of $40.834 per share over the five days prior to settlement.

Is the December 15, 2025 repurchase part of EXL’s $500 million repurchase program (EXLS)?

No. The repurchase from Orogen Echo LLC was completed under a separate Stock Purchase Agreement and is separate from the $500 million program.

How much capital did EXL use for the private repurchase on December 15, 2025 (EXLS)?

The aggregate purchase price was $63,373,143, representing the capital deployed for this private transaction.

Will Vikram Pandit remain on EXL’s board after the December 15, 2025 repurchase (EXLS)?

Yes. Orogen’s CEO Vikram Pandit will remain on EXL’s board as Lead Independent Director.